Invention Application
- Patent Title: THERAPEUTIC COMPOUNDS AND USES THEREOF
-
Application No.: US15658213Application Date: 2017-07-24
-
Publication No.: US20180009805A1Publication Date: 2018-01-11
- Inventor: Marc Adler , Daniel J. Burdick , Terry Crawford , Martin Duplessis , Steven R. Magnuson , Christopher G. Nasveschuk , Anthony F. Romero , Yong Tang , Vickie Hsiao-Wei Tsui , Shumei Wang
- Applicant: GENENTECH, INC. , CONSTELLATION PHARMACEUTICALS, INC.
- Applicant Address: US CA South San Francisco US MA Cambridge
- Assignee: GENENTECH, INC.,CONSTELLATION PHARMACEUTICALS, INC.
- Current Assignee: GENENTECH, INC.,CONSTELLATION PHARMACEUTICALS, INC.
- Current Assignee Address: US CA South San Francisco US MA Cambridge
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61K45/06 ; A61K31/506 ; A61K31/437 ; A61K31/4545 ; A61K31/444 ; C07D519/00 ; A61K31/5377
Abstract:
The present invention relates to compounds of formula (I): and to salts thereof, wherein R1-R6 have any of the values defined in the specification, and compositions and uses thereof. The compounds are useful as inhibitors of TAF1. Also included are pharmaceutical compositions comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof, and methods of using such compounds and salts in the treatment of various TAF1-mediated disorders.
Public/Granted literature
- US10202378B2 Therapeutic compounds and uses thereof Public/Granted day:2019-02-12
Information query
